Stryker Neurovascular
Business and Technology Park, Cork Munster, IE
Registered product codes
10 product codes
Recent MDR events
9,448 on file
- NEUROFORM ATLAS 4.0MM X 21MM NO TIP - CEJul 31, 2026Malfunction3008881809-2026-00481
- TARGET 360 NANO 1MM X 2CMJul 31, 2026Injury3008881809-2026-00483
- NEUROFORM ATLAS 4.0MM X 21MM NO TIP - CEJul 31, 2026Malfunction3008881809-2026-00484
- NEUROFORM ATLAS 3.0MM X 21MM NO TIP - CEJul 31, 2026Malfunction3008881809-2026-00485
- SYNCHRO SELECT-14 STANDARD ST 215CMJul 30, 2026Malfunction3012931345-2026-00124
- TARGET 360 ULTRA 4MM X 15CMJul 30, 2026Malfunction3008881809-2026-00480
- SYNCHRO2-14 SOFT STRAIGHT 200CMJul 30, 2026Injury3012931345-2026-00125
- SYNCHRO SELECT-14 SUPPORT ST 215CMJul 29, 2026Malfunction3012931345-2026-00122
- SURPASS ELITE FDS 3.75MM X 15MM - CEJul 28, 2026Injury3008881809-2026-00478
- SYNCHRO SELECT-14 STANDARD ST 300CMJul 28, 2026Malfunction3012931345-2026-00123
Recalls
109 on file
- Open, ClassifiedJun 24, 2026
Embolization coil detachment system devices may experience premature battery drain causing devices to: 1) Not power on; 2) Power on with faint audible and visual indicators; 3) Be unable to detach a coil as intended, which may necessitate medical intervention if the procedure must be completed with an alternative technique.
View FDA record ↗ - Open, ClassifiedOct 7, 2024
Stryker Neurovascular has observed that devices with Out of United States (OUS) approved Instructions for Use (IFU) and Packaging Labels (pouch and carton), different configurations, have been erroneously distributed to customers in the US.
View FDA record ↗ - Open, ClassifiedMay 31, 2024
Stryker Neurovascular has observed an increased frequency of PTFE coating damage occurring on the Synchro Guidewires that may be caused by the practice of backloading the guidewire through the optional introducer accessory. This issue is limited to certain lots of the Synchro Guidewire that contain an older version of the introducer accessory. Due to variation in the manufacturing process of the supplier of the introducer accessory, certain lots of introducers have sharper than intended edges that can peel off the PTFE coating when physicians use a technique known as backloading. Users with impacted product in their inventory are cautioned not to use this backloading technique.
View FDA record ↗ - Open, ClassifiedMay 31, 2024
Stryker Neurovascular has observed an increased frequency of PTFE coating damage occurring on the Synchro Guidewires that may be caused by the practice of backloading the guidewire through the optional introducer accessory. This issue is limited to certain lots of the Synchro Guidewire that contain an older version of the introducer accessory. Due to variation in the manufacturing process of the supplier of the introducer accessory, certain lots of introducers have sharper than intended edges that can peel off the PTFE coating when physicians use a technique known as backloading. Users with impacted product in their inventory are cautioned not to use this backloading technique.
View FDA record ↗ - Open, ClassifiedMay 31, 2024
Stryker Neurovascular has observed an increased frequency of PTFE coating damage occurring on the Synchro Guidewires that may be caused by the practice of backloading the guidewire through the optional introducer accessory. This issue is limited to certain lots of the Synchro Guidewire that contain an older version of the introducer accessory. Due to variation in the manufacturing process of the supplier of the introducer accessory, certain lots of introducers have sharper than intended edges that can peel off the PTFE coating when physicians use a technique known as backloading. Users with impacted product in their inventory are cautioned not to use this backloading technique.
View FDA record ↗ - Open, ClassifiedMay 28, 2024
Neurovascular devices did not meet the minimum sample size required for endotoxin testing during manufacturing processes and are out of compliance with the AAMI ST72 standard, so these devices may exceed the acceptable limits of endotoxin levels; high levels of endotoxins may increase the risk of fever, shock and aseptic meningitis.
View FDA record ↗ - Open, ClassifiedMay 28, 2024
Neurovascular devices did not meet the minimum sample size required for endotoxin testing during manufacturing processes and are out of compliance with the AAMI ST72 standard, so these devices may exceed the acceptable limits of endotoxin levels; high levels of endotoxins may increase the risk of fever, shock and aseptic meningitis.
View FDA record ↗ - Open, ClassifiedMay 28, 2024
Neurovascular devices did not meet the minimum sample size required for endotoxin testing during manufacturing processes and are out of compliance with the AAMI ST72 standard, so these devices may exceed the acceptable limits of endotoxin levels; high levels of endotoxins may increase the risk of fever, shock and aseptic meningitis.
View FDA record ↗ - Open, ClassifiedMay 28, 2024
Neurovascular devices did not meet the minimum sample size required for endotoxin testing during manufacturing processes and are out of compliance with the AAMI ST72 standard, so these devices may exceed the acceptable limits of endotoxin levels; high levels of endotoxins may increase the risk of fever, shock and aseptic meningitis.
View FDA record ↗ - Open, ClassifiedMay 28, 2024
Neurovascular devices did not meet the minimum sample size required for endotoxin testing during manufacturing processes and are out of compliance with the AAMI ST72 standard, so these devices may exceed the acceptable limits of endotoxin levels; high levels of endotoxins may increase the risk of fever, shock and aseptic meningitis.
View FDA record ↗
Compliance history
Matched by FEI 3008881809.
FDA inspections
0 on file
No inspections on file for this FEI number.
Inspection citations
0 on file
No citations on file for this FEI number.
Compliance actions
0 on file
No warning letters or injunctions on file for this FEI number.
Import refusals
0 on file
No import refusals on file for this FEI number.